Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best affordable stocks with good earnings growth for 2026. Halozyme ...
The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 ...
The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.
GlobalData on MSN
Revamping best-selling drugs to combat patent cliff has limits
Updated versions of best-selling drugs may mitigate some of the impact of patent cliff losses, but the strategy behind the ...
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle ...
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Altimmune ($ALT) announced an update on their ongoing clinical study. Altimmune’s IMPACT trial, officially titled “A Phase 2, Multicenter, ...
Next to a house, a car is the most expensive purchase most people will make. If you're financing your vehicle, choosing the right lender can save you thousands in interest and fees. There's a lot to ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback